Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31true2023-01-01falseNo description of principal activity22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 13963301 2023-01-01 2023-12-31 13963301 2022-03-08 2022-12-31 13963301 2023-12-31 13963301 2022-12-31 13963301 c:Director1 2023-01-01 2023-12-31 13963301 c:Director2 2023-01-01 2023-12-31 13963301 d:CurrentFinancialInstruments 2023-12-31 13963301 d:CurrentFinancialInstruments 2022-12-31 13963301 d:Non-currentFinancialInstruments 2023-12-31 13963301 d:Non-currentFinancialInstruments 2022-12-31 13963301 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 13963301 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 13963301 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 13963301 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 13963301 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-12-31 13963301 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2022-12-31 13963301 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2023-12-31 13963301 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2022-12-31 13963301 d:ShareCapital 2023-12-31 13963301 d:ShareCapital 2022-12-31 13963301 d:RetainedEarningsAccumulatedLosses 2023-12-31 13963301 d:RetainedEarningsAccumulatedLosses 2022-12-31 13963301 c:OrdinaryShareClass1 2023-01-01 2023-12-31 13963301 c:OrdinaryShareClass1 2023-12-31 13963301 c:OrdinaryShareClass1 2022-12-31 13963301 c:FRS102 2023-01-01 2023-12-31 13963301 c:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 13963301 c:FullAccounts 2023-01-01 2023-12-31 13963301 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 13963301 d:Subsidiary1 2023-01-01 2023-12-31 13963301 d:Subsidiary1 1 2023-01-01 2023-12-31 13963301 6 2023-01-01 2023-12-31 13963301 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13963301









KNP HEALTHCARE LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2023

 
KNP HEALTHCARE LIMITED
REGISTERED NUMBER: 13963301

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Investments
 4 
3,197,008
3,478,785

  
3,197,008
3,478,785

Current assets
  

Debtors: amounts falling due after more than one year
 5 
265,563
-

Debtors: amounts falling due within one year
 5 
-
14,780

Cash at bank and in hand
 6 
1,403
19,029

  
266,966
33,809

Creditors: amounts falling due within one year
 7 
(257,090)
(66,820)

Net current assets/(liabilities)
  
 
 
9,876
 
 
(33,011)

Total assets less current liabilities
  
3,206,884
3,445,774

Creditors: amounts falling due after more than one year
 8 
(3,206,320)
(3,445,435)

  

Net assets
  
564
339


Capital and reserves
  

Called up share capital 
 10 
100
100

Profit and loss account
  
464
239

  
564
339


Page 1

 
KNP HEALTHCARE LIMITED
REGISTERED NUMBER: 13963301
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
K Patel
................................................
N Patel
Director
Director


Date: 12 August 2024

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

KNP Healthcare Limited is a private company limited by shares. The company is incorporated in England and Wales and its registered office Aston House, Cornwall Avenue, London N3 1LF. The company registration number is 13963301.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.3

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.5

Impairment of fixed assets and goodwill

Assets that are subject to depreciation or amortisation are assessed at each balance sheet date to determine whether there is any indication that the assets are impaired. Where there is any indication that an asset may be impaired, the carrying value of the asset (or cash-generating unit to which the asset has been allocated) is tested for impairment. An impairment loss is recognised for the amount by which the asset's carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset's (or CGU's) fair value less costs to sell and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (CGUs). Non-financial assets that have been previously impaired are reviewed at each balance sheet date to assess whether there is any indication that the impairment losses recognised in prior periods may no longer exist or may have decreased.

 
2.6

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Page 3

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
Page 4

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)


2.10
Financial instruments (continued)



3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2022 - 2).


4.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2023
3,478,785


Disposals
(259,777)


Amounts reclassified
(22,000)



At 31 December 2023
3,197,008







The following was a subsidiary undertaking of the Company:

Name

Registered office

Class of shares

Holding

Cootes Pharmacy Limited
Aston House, Cornwall Avenue. London N3 1LF
ordinary
100%

The aggregate of the share capital and reserves as at 31 December 2023 and the profit or loss for the year ended on that date for the subsidiary undertaking were as follows:

Name
Aggregate of share capital and reserves
Profit/(Loss)

Cootes Pharmacy Limited
187,589
128,049


5.


Debtors

2023
2022
Page 5

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

5.Debtors (continued)

£
£

Due after more than one year

Amounts owed by group undertakings
265,563
-

265,563
-


2023
2022
£
£

Due within one year

Other debtors
-
14,780

-
14,780



6.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
1,403
19,029

1,403
19,029



7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
180,657
-

Corporation tax
56
56

Other taxation and social security
9,364
-

Other creditors
64,763
64,764

Accruals and deferred income
2,250
2,000

257,090
66,820


Page 6

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

8.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
1,290,109
1,545,366

Amounts owed to group undertakings
-
26,814

Other creditors
1,916,211
1,873,255

3,206,320
3,445,435



9.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
180,657
-


180,657
-

Amounts falling due 1-2 years

Bank loans
180,657
-


180,657
-


Amounts falling due after more than 5 years

Bank loans
1,109,452
1,545,366

1,109,452
1,545,366

1,470,766
1,545,366



10.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 (2022 - 100) ordinary shares of £1.00 each
100
100


Page 7

 
KNP HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

11.


Related party transactions

At the balance sheet date, a sum of £265,563 (2022 : £26,814 to) was owed to the company from  Cootes Pharmacy Limited, it's wholly owned subsidiary company.  During the period, the company received management fees totalling £123,000 (2022 : £30,000) from its subsidiary. 

 
Page 8